Citation Impact
Citing Papers
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Fosfomycin
2016
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table
2004
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Structure and function of matrix metalloproteinases and TIMPs
2006 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer
2000
Bone Marrow–Derived Cells Do Not Contribute Significantly to Collagen I Synthesis in a Murine Model of Renal Fibrosis
2006 StandoutNobel
Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues
2003
Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review
2018
How Good is MRI at Detecting and Characterising Cancer within the Prostate?
2006
Trials of prostate-cancer screening are not worthwhile
2009
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Tumor size predicts the survival of patients with pathologic stage t2 bladder carcinoma
1999
Initial High-Grade T1 Urothelial Cell Carcinoma: Feasibility and Prognostic Significance of Lamina Propria Invasion Microstaging (T1a/b/c) in BCG-Treated and BCG-Non-Treated Patients
2005
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer
1999
Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance
2003
A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?
2004
Measurements of T1‐relaxation in ex vivo prostate tissue at 132 μT
2012 StandoutNobel
Trendsin Molecular Medicine: Matrix metalloproteinases and their inhibitors in tumour growth and invasion
1999
The Matrix Metalloproteinases and Their Inhibitors in the Treatment of Pancreatic Cancer
1999
The Hallmarks of Cancer
2000 Standout
Prognostic Implication of Microvascular Invasion in Biochemical Failure in Patients Treated with Radical Prostatectomy
2003
Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management
2016
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
2007
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
2007 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Diabetes, oxidative stress, and antioxidants: A review
2003 Standout
Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example
2012
High-tech in radiation oncology: should there be a ceiling?
2004
Bladder cancer
2016 Standout
THE INFLUENCE OF THE LEVEL OF LAMINA PROPRIA INVASION AND THE PREVALENCE OF P53 NUCLEAR ACCUMULATION ON SURVIVAL IN STAGE T1 TRANSITIONAL CELL BLADDER CANCER
1998
Remodelling the extracellular matrix in development and disease
2014 Standout
Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin
2011
The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder
1998 Standout
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Smoking Status Is a Risk Factor for Recurrence After Transurethral Resection of Non–Muscle-Invasive Bladder Cancer
2011
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Urothelial Transitional Cell Carcinoma with Endophytic Growth Patterns
1997
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
2015
Cholinergic innervation and function in the prostate gland
2002
Non-motor features of Parkinson disease
2017 Standout
Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression
1998
Developmental reprogramming of cancer susceptibility
2012
Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma—a placebo controlled study
1999
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Matrix metalloproteinases in tumor invasion and metastasis
2000
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Prognostic Factors in Stage T1 Bladder Cancer: Tumor Pattern (Solid or Papillary) and Vascular Invasion More Important than Depth of Invasion
2007
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Mechanism of Quinolone Action and Resistance
2014 Standout
Changing views of the role of matrix metalloproteinases in metastasis
1997
Matrix Metalloproteinases
1997
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
Molecular biology and targeted therapies for urothelial carcinoma
2015
Matrix Metalloproteinases
1999 Standout
The pathology of bladder cancer
2006
Perineural invasion in cancer
2009 Standout
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
2011
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Cancer-Related Axonogenesis and Neurogenesis in Prostate Cancer
2008
Bladder Cancer
2020 Standout
Lymphovascular Invasion of Urothelial Cancer in Matched Transurethral Bladder Tumor Resection and Radical Cystectomy Specimens
2008
Expectant Management of Small, Recurrent, Noninvasive Papillary Bladder Tumors
2003
LYMPHOVASCULAR INVASION INDEPENDENTLY PREDICTS INCREASED DISEASE SPECIFIC SURVIVAL IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE UPPER URINARY TRACT
2005
Mechanisms of Estrogen Action
2001 Standout
Lymphovascular Invasion in Transurethral Resection Specimens as Predictor of Progression and Metastasis in Patients With Newly Diagnosed T1 Bladder Urothelial Cancer
2009
The MicroRNA Spectrum in 12 Body Fluids
2010 Standout
Management of Upper Tract Urothelial Carcinoma
2009
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
1998
Regulation of matrix metalloproteinase expression in tumor invasion
1999 Standout
Obstructive nephropathy and renal fibrosis
2002
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
2003 Standout
The Importance of the Depth of Invasion in Stage T1 Bladder Carcinoma: A Prospective Cohort Study
1997
Reproducibility and Prognostic Variability of Grade and Lamina Propria Invasion in Stages Ta, T1 Urothelial Carcinoma of the Bladder
2003
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
2002
OUTCOMES AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN ARE NOT AFFECTED BY SUBSTAGING OF HIGH GRADE T1 TRANSITIONAL CELL CARCINOMA
2000
Predicting Cancer Progression in Patients With Stage T1 Bladder Carcinoma
1999
Prostate-Specific Antigen–Based Screening for Prostate Cancer
2018
Neonatal exposure of male rats to estradiol benzoate causes rete testis dilation and backflow impairment of spermatogenesis
1998
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Radical Cystectomy for Carcinoma of the Bladder: Critical Evaluation of the Results in 1,026 Cases
1997
PROGNOSTIC SIGNIFICANCE OF LYMPHOVASCULAR INVASION OF BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY
2005
THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER
2000
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of J.C. Angulo being referenced
Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer
1997
Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC)
2014
Adenocarcinoma of the rete testis
1995
Extent of Prostate-Specific Antigen Contamination in the Spanish Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
2006
In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology
1999
One-incision nephroureterectomy endoscopically assisted by transurethral ureteral stripping
1998
Treatment with Acarbose May Improve Endothelial Dysfunction in Streptozotocin-Induced Diabetic Rats
2000
Autocrine Regulation of Human Prostate Carcinoma Cell Proliferation by Somatostatin through the Modulation of the SH2 Domain Containing Protein Tyrosine Phosphatase (SHP)-1
2002
Muscularis mucosa differentiates two populations with different prognosis in Stage T1 bladder cancer
1995
Urothelial Carcinoma of the Prostate
2007
The prognostic significance of vascular invasion in stage T1 bladder cancer
1995
Etiología y sensibilidad de los uropatógenos identificados en infecciones urinarias bajas no complicadas de la mujer (Estudio ARESC): implicaciones en la terapia empírica
2010
Efecto del tabaco sobre la evolución de los tumores de vejiga
2007
Re-exéresis mediante cirugía de Mohs de carcinomas basocelulares de la cabeza previamente extirpados con afectación de márgenes
2011
Estudio comparativo aleatorizado para la evaluación de un nuevo esquema terapéutico de fosfomicina trometamol en mujeres posmenopáusicas con infección no complicada del tracto urinario inferior
2012
Eficacia y seguridad de fosfomicina-trometamol en la profilaxis de la biopsia transrectal de la próstata: estudio prospectivo aleatorizado comparativo con ciprofloxacino
2014
Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial
2012
Segunda resección transuretral y pronóstico del cáncer de vejiga no músculo-invasivo de alto grado en pacientes que no reciben bacilo de Calmette-Guérin
2014
Primary Cisplatin, Methotrexate and Vinblastine Aiming at Bladder Preservation in Invasive Bladder Cancer: Multivariate Analysis on Prognostic Factors
1996
Role of autonomic innervation in rat prostatic structure maintenance: a morphometric analysis.
1998
Mohs Micrographic Surgery for Re-Excision of Basal Cell Carcinomas on the Head With Positive Margins
2011
Susceptibility of a grass-pollen oral immunotherapy extract to the saliva and gastric fluid digestive process.
1994
[Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease].
1995
Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin
2014
[Survival in stage T2-T3A bladder cancer treated with radical cystectomy].
1997
ROLE OF AUTONOMIC INNERVATION IN RAT PROSTATIC STRUCTURE MAINTENANCE: A MORPHOMETRIC ANALYSIS
1998
Comparison of Digital RectalExamination, TransrectalUltrasonography, and MulticoilMagnetic Resonance Imaging forPreoperative Evaluation of ProstateCancer
1997
Randomized comparative study for the assessment of a new therapeutic schedule of fosfomycin trometamol in postmenopausal women with uncomplicated lower urinary tract infection
2013
High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
1996
Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving Bacillus Calmette-Guérin
2014